Promethazine Hydrochloride Tablet
Product Images NDC 0591-5307

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Promethazine Hydrochloride (NDC 0591-5307). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of Promethazine Hydrochloride showing the molecular arrangement including two benzene rings connected by a sulfur and nitrogen atom, with additional hydrocarbon side chains and a hydrochloride (HCl) group.*

FDA Label Image

Image 2

Promethazine Hydrochloride Tablets USP 25 mg packaging label showing NDC 0591-5307-01 by Actavis Pharma, Inc. The label indicates 100 tablets, prescription only. It includes storage instructions, manufacturer information (Watson Pharma Private Limited, India), and a barcode.*

FDA Label Image

Image 3

Promethazine Hydrochloride Tablets USP, 50 mg, label for a bottle containing 100 tablets. The label includes the product name, strength, manufacturer Watson Pharma Private Limited in India, and distributor Actavis Pharma, Inc. in New Jersey, USA. It also shows storage instructions, dosage guidance to see package insert, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.